PCG Appoints Dr. Charles Simone as Chair of the PCG Executive Council

PCG is thrilled to announce that Charles Simone, MD, from the Maryland Proton Treatment Center, has been appointed as the Chairman of the PCG Executive Council. Dr. Simone currently serves as the chair of the PCG Lung Committee and will now also lead the Council’s efforts to provide oversight for all PCG committees, protocol development and approvals, clinical policies and procedures, and organizational strategy implementation. Congratulations Dr. Simone!

(more…)

Topics: |

PCG Welcomes Mayo Clinic To Our Membership!

PCG welcomes Mayo Clinic to our membership!
Mayo Clinic’s existing proton center in Minnesota opened in 2015 and the new center in Arizona is scheduled to begin treating patients in Spring 2016 . We are thrilled to be working with the teams from both locations!
Click below to learn more about the centers:
http://www.mayoclinic.org/…/ra…/proton-beam-therapy/overview

proton-beam-az

Topics: |

PCG Member Spotlight: Carl Rossi, Jr., MD, Scripps Proton Therapy Center

Dr. Rossi is a board certified radiation oncologist, specializing in proton beam therapy, specifically for prostate cancers and lymphomas and serves as the medical director of Scripps Proton Therapy Center.  Dr. Rossi previously served as chief of genito-urinary and lymphoma radiation oncology services at Loma Linda University Medical Center and also served as an associate professor of radiation oncology. During his tenure at Loma Linda, Dr. Rossi treated more than 9,000 prostate cancer patients with proton therapy. Dr. Rossi has published more than 20 peer-reviewed articles, as well as contributed chapters to definitive textbooks on radiation oncology.  Dr. Rossi earned his medical degree from Loyola University Stritch School of Medicine in 1988 and did his internship and residency at Loma Linda University Medical Center in radiation oncology. Dr. Rossi currently serves as the PCG principal investigator for Scripps Proton Therapy Center and is a member of both the PCG Genito-Urinary and Lymphoma Disease Site Committees.

Topics: |